Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Alligator Bioscience presents at the SITC 35th Annual Meeting

Three projects showcased   -  ATOR-1015, ALG.APV-527 and Neo-X-Prime  -Lund, Sweden, November 9, 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that it will present data from three immuno-oncology projects at the Society for Immunotherapy of Cancer’s (SITC) 35th Virtual Annual Meeting, November 9-14, 2020. The presentations will include the Phase I study of ATOR-1015, the Phase I-ready ALG.APV-527 developed in partnership with Aptevo Therapeutics, as well as the novel bispecific concept Neo-X-Prime. “The fact that three of our immuno-oncology projects have

Arcus ASA: Supplement to the prospectus prepared for the merger of Altia Plc and Arcus ASA

THIS STOCK EXCHANGE RELEASE MAY NOT BE PUBLISHED OR DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR RULES OR WOULD REQUIRE ADDITIONAL DOCUMENTS TO BE COMPLETED OR REGISTERED OR REQUIRE ANY MEASURE TO BE UNDERTAKEN IN ADDITION TO THE REQUIREMENTS UNDER FINNISH LAW. FOR FURTHER INFORMATION, SEE “IMPORTANT NOTICE” BELOW.The Finnish Financial Supervisory Authority has approved a supplement to the prospectus prepared for the

The Finnish Financial Supervisory Authority has approved a supplement to the prospectus prepared for the merger of Altia Plc and Arcus ASA

ALTIA PLC  STOCK EXCHANGE RELEASE  9 NOVEMBER 2020 AT 3:00 p.m. EET THIS STOCK EXCHANGE RELEASE MAY NOT BE PUBLISHED OR DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR RULES OR WOULD REQUIRE ADDITIONAL DOCUMENTS TO BE COMPLETED OR REGISTERED OR REQUIRE ANY MEASURE TO BE UNDERTAKEN IN ADDITION TO THE REQUIREMENTS UNDER FINNISH LAW. FOR FURTHER INFORMATION, SEE “IMPORTANT NOTICE” BELOW. The Finnish Financial Supervisory

TePe commits to climate action by setting a CO₂ neutrality goal

Committing to the UN Goals and the urgent need to take climate action, TePe has taken on the challenge of achieving carbon neutrality in products and packaging in 2022.‘Taking action to combat climate change and its impacts is one of the greatest challenges of our time. To tackle this challenge, we need to reduce our carbon emissions and move towards a fossil-free society. At TePe, we want to contribute to a positive development. Our CO₂ neutrality goal will be a catalyst for our sustainability initiatives and a step towards our overarching goal to become a CO₂ neutral company’, says Helena

The success of an omnichannel strategy thanks to UGC

As an expert in tailor-made blinds and curtains, Heytens has provided their customers with window decorations for more than 50 years. The brand started using Flowbox in early 2019, and has been consistently developing its communication objectives ever since. Implementing user-generated content (UGC) in their social media strategy strengthened their community and improved the customer journey. “At Heytens, we’re always looking to inspire with visual content allowing our clients to imagine what our products will look like in their own homes,” says Anaïs André, Digital Marketing Manager at

Stena Line moves to Stockholm Norvik Port

Ferry company Stena Line moves its Nynäshamn ferry terminal to the newly built Stockholm Norvik Port. On 9 November the terminal was officially opened with the first arrival of the vessel Stena Flavia at 7 a.m. The new ferry terminal is an important part of Stena Lines expansion plans in the Baltic Sea that includes the deployment of two new modern ferries and 30 % additional freight capacity on the Nynäshamn-Ventspils route in 2021.Stena line is one of the world’s leading ferry companies with 18 ferry routes in Europe. Three of them are operating across the Baltic Sea. Stena Line recently

Major shareholder announcement – Société Générale S.A.’s holding as at 4 November 2020

Vestas Wind Systems A/S, Aarhus, 9 November 2020Company announcement No. 39/2020   Major shareholder announcement – Société Générale S.A.’s holding as at 4 November 2020 Pursuant to Section 30 of the Danish Capital Markets Act, Vestas Wind Systems A/S hereby informs that the company has been notified on 9 November 2020 that Société Générale S.A, 29 Boulevard Haussmann, 75009 Paris, France, on 4 November 2020 had a holding of voting rights and share capital attached to the Vestas share corresponding to a position of 3.21 percent (previously 6.26 percent) of the total share capital

Stena Line moves to Stockholm Norvik Port

Ferry company Stena Line moves its Nynäshamn ferry terminal to the newly built Stockholm Norvik Port. On November 9th the terminal was officially opened with the first arrival of the vessel Stena Flavia at 7 a.m. The new ferry terminal is an important part of Stena Lines expansion plans in the Baltic Sea that includes the deployment of two new modern ferries and 30 % additional freight capacity on the Nynäshamn-Ventspils route in 2021.Stena Line is one of the world’s leading ferry companies with 18 ferry routes in Europe. Three of them are operating across the Baltic Sea. Stena Line

NextCell has formally kicked-off its Eurostars funded project ‘ Bioscale ’

NextCell Pharma AB (“NextCell” or the “Company”) announces today that it, in cooperation with the consortium members: MyCellHub, SEFA and Scinus Cell Expansion, now officially has kicked-off the earlier announced Eurostars project. The Eurostars project Bioscale will focus on using a novel cell expansion system developed by Scinus Cell Expansion, to further test, develop and validate the involved bioprocesses used in the production of NextCell’s drug candidate ProTrans™ (ProTrans).· NextCell has been granted €470,000 of a Eurostar grant totalling €1.6M. The total budget of the project is €2.

Neles strengthens its distributor network with 13 new partners in India, Sri Lanka, and Bangladesh

Neles Corporation’s press release on November 9, 2020, at 1:15 p.m. EETNeles signed 13 new distributor agreements in India, Sri Lanka, and Bangladesh in the second quarter of 2020. The new distributors help to further expand the coverage of Neles’ valve offering in the various customer industries of their respective countries. The agreements cover the following companies: · SureSales Automation Pvt Ltd (SAPL), Delhi · SB Enterprise, Kolkata · Fluidline Systems, Chennai · Equipment Fabricators & Traders (EFT), Chennai · Instrumech Engineers Pvt Ltd, Mumbai · Sunbeam

STONEHAVEN CONSULTING EXPANDS IN TERMS OF GEOGRAPHY AND PEOPLE

· Opening new office in Switzerland · Strengthening global team with new industry experts · Providing specialist life science consulting servicesStonehaven Consulting AG, a boutique consultancy firm supporting life sciences companies at various phases of development around the world, recently opened its new office in the greater Zurich area and expanded its office in London. As part of the ongoing strengthening of its global team, the company has also hired several people: · Rebeca Garcia Escudero, Analyst  · Katja Glauser, Analyst (

KVÆRNER ASA: UPDATE ON THE CONTEMPLATED MERGER WITH AKER SOLUTIONS ASA

CORRETION: Specification in approval date for merger.   NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. 9 November 2020 – Reference is made to the previous stock exchange announcements made by Kværner ASA (“Kvaerner”) regarding the contemplated merger with Aker Solutions ASA (“Aker

Brighter’s pioneering diabetes management solution Actiste® receives market approval in the United Arab Emirates

Brighter AB (publ) is proud to announce that its pioneering solution for improved diabetes management, Actiste®, has received market approval from the UAE Ministry of Health and Prevention (“MOHAP”). Some additional regulatory approvals for consumables included within the Actiste® Diabetes Management as a Service (“Actiste Service”) offering are still outstanding but underway. “The market approval in the UAE is a vital milestone allowing Brighter to start engaging with real-world patients and making a difference in their everyday life. We are glad to now be able to actively contribute to

Invitation to Noreco Third Quarter 2020 Earnings Call

Norwegian Energy Company ASA (“Noreco” or “the Company”) will publish its financial results for the third quarter 2020 on Wednesday 11 November 2020 at 07:00 (CET). A conference call, available as a webcast, will be hosted at 12:00 (CET).  To join webcast: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20201111_8   ***  Contact:Cathrine Torgersen, EVP Investor Relations & CommunicationsPhone: +47 915 28 501Email: ct@noreco.com

HiQ provides support for InfoSolutions’ mobile Covid-19 testing

HiQ is assisting InfoSolutions with their assignment from the Public Health Agency of Sweden (Folkhälsomyndigheten) to increase national accessibility of testing for Covid-19. It involves PCR testing, which diagnoses active coronavirus infection.“This is the second project we’ve participated in that aims to reduce the impact of Covid-19 on the world. It’s nice to see that our broad knowledge in digitalising the healthcare sector and e-health will help control the pandemic,” says Helena Forsmark, Managing Director of HiQ Stockholm.HiQ’s assignment is to be the principal project manager

Buile Hill Academy awarded national Leading Parent Partnership Award

Salford, UK, 9[th] November 2020 – Salford-based Buile Hill Academy, part of the Consilium Academies Multi-Academy Trust, has been awarded the prestigious Leading Parent Partnership Award (LLPA) for its commitment to investing in parent and carer communications to ensure the success of pupils.Salford-based Buile Hill Academy, part of the Consilium Academies Multi-Academy Trust , has been awarded the prestigious Leading Parent Partnership Award (LLPA) for its commitment to investing in parent and carer communications to ensure the success of pupils.   The award,

Loza Foundation’s latest aid project: 17-year old Lirija drops everything to help her blind mother

In a shed on the outskirts of the town of Shutka in North Macedonia, 17-year old Lirija lives with her blind mother, Saadet. The shed consists of one room that serves as a bedroom, kitchen and bathroom combined. There is no toilet and every time it rains, the shed is flooded with rainwater. Lirija has hardly any teeth left and the other pupils are ostracising her at school; a school she can no longer attend as she has to spend her days gathering metal and plastics to provide for her and her mother. Saadet and Lirija. About a year ago, Lirija met Sabina Grubbeson, the founder of

Invitation to Catellas Q3 interim report audiocast conference call on 12 November

Catella AB (publ) will publish its Q3 interim report on Thursday 12 November at 07.00. In connection with the report, Catella will hold a webcast conference call in English at 09.00 the same day.Catella will be represented by acting CEO Johan Claesson and CFO Christoffer Abramson, who will present the report and answer questions. Information regarding telephone numbers and website is available at:https://financialhearings.com/event/12559 The presentation used in the conference will be available at https://www.catella.com/en/investor-relations/reports-and-presentations after

BioStock: Eventful stock market journey for Respiratorius in Q3

Last week, Respiratorius released its report for the third quarter of 2020. The company can look back on an eventful period with significant stock gains while waiting for an exit announcement regarding the main candidate VAL001. BioStock has spoken with CEO Johan Drott about the past quarter and what happens next.Read the full article at biostock.se: https://www.biostock.se/en/eventful-stock-market-journey-for-respiratorius-in-q3/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Dr. Alex Rovira from Hospital Vall d’Hebron joins SyntheticMR’s Medical Advisory Board

SyntheticMR welcomes Dr Alex Rovira to their Medical Advisory Board to support their company with clinical expertise.Dr Rovira is Head of Neuroradiology at Vall d'Hebron Hospital in Barcelona and a Professor of Radiology and Neuroimmunology. He is specialized in diagnostic neuroradiology with particular interest in demyelinating diseases, stroke, neuro-oncology and head and neck tumors. He is past president of the European Society of Neuroradiology and served as Co-Chairman of MAGNIMS (European Multicenter Collaborative Research Network on MRI in MS). He is on the editorial boards of

Boliden and Luleå University of Technology enter into a collaboration agreement

Boliden and Luleå University of Technology are today entering in to a long-term strategic collaboration agreement. The new agreement means that collaboration will be enhanced in terms of competence provision and competence development, as well as research and innovation towards leading positions within automation and resource utilization.Boliden has long collaborated with Luleå University of Technology, with a focus on developing technology and strengthening competence in both mining and smelting operations. The university has also been an important recruitment base for Boliden.  “

Interim report January – September 2020

High growth and good profitabilityJuly – September 2020 · Net sales increased by 16.1 percent to SEK 1,643 (1,416) million. Organic growth, adjusted for currency effects, was -2.7 (14.6) percent. · EBIT increased to SEK 140 (113) million, which corresponds to an EBIT margin of 8.5 (8.0) percent. · Cash flow from operating activities for the period was SEK 90 (114) million. · Six acquisitions were made during the quarter, which on an annual basis contribute an estimated total sales of SEK 496 million. · Earnings per share for the period amounted to SEK 2.01 (1.59).

There are no items matching the current filter
There are no more items matching the current filter
Back to top